These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19955905)

  • 1. What information do public organizations provide to Belgian women on primary prevention of breast cancer?
    Liebens F; Aimont M; Beauraing F; Carly B; Cusumano P; Rozenberg S
    Eur J Cancer Prev; 2010 Jan; 19(1):68-70. PubMed ID: 19955905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.
    Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L
    Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing the support needs of women at high risk for breast cancer: evidence-based care by advanced practice nurses.
    Stacey D; DeGrasse C; Johnston L
    Oncol Nurs Forum; 2002 Jul; 29(6):E77-84. PubMed ID: 12096298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographic and psychosocial factors associated with risk perception for breast cancer.
    Pöhls UG; Fasching PA; Beck H; Kaufmann M; Kiechle M; von Minckwitz G; Paepke S; Schultz-Zehden B; Schwarz-Boeger U; Beckmann MW
    Oncol Rep; 2005 Dec; 14(6):1605-13. PubMed ID: 16273264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
    Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs.
    Fasching PA; von Minckwitz G; Fischer T; Kaufmann M; Schultz-Zehden B; Beck H; Lux MP; Jacobs V; Meden H; Kiechle M; Beckmann MW; Paepke S
    Breast Cancer Res Treat; 2007 Jan; 101(1):95-104. PubMed ID: 17033928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors.
    Bober SL; Hoke LA; Duda RB; Regan MM; Tung NM
    J Clin Oncol; 2004 Dec; 22(24):4951-7. PubMed ID: 15598980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the breast cancer education and risk assessment program.
    Snyder LA; Soballe DB; Lahl LL; Nehrebecky ME; Soballe PW; Klein PM
    Oncol Nurs Forum; 2003; 30(5):803-8. PubMed ID: 12949593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors and risk reduction of breast cancer].
    Nkondjock A; Ghadirian P
    Med Sci (Paris); 2005 Feb; 21(2):175-80. PubMed ID: 15691489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Women at high risk for breast cancer: can we define a group of women in France who could participate in a prevention trial?].
    Lê MG; Plu-Bureau G
    Contracept Fertil Sex; 1995 Mar; 23(3):199-202. PubMed ID: 7728186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does enhanced information at cancer genetic counseling improve counselees' knowledge, risk perception, satisfaction and negotiation of information to at-risk relatives?--a randomized study.
    Roshanai AH; Rosenquist R; Lampic C; Nordin K
    Acta Oncol; 2009; 48(7):999-1009. PubMed ID: 19636983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Breast cancer: selected risk factors, primary prevention].
    Stasiołek D; Kwaśniewska M; Drygas W
    Przegl Lek; 2002; 59(1):26-30. PubMed ID: 12108043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and prevention of breast cancer in primary care.
    Tice JA; Kerlikowske K
    Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemoprevention of breast cancer: a literature review and report on the current status in Germany].
    Paepke S; V Minckwitz G; Kaufmann M; Schwarz-Boeger U; Jacobs VR; Aigner M; Pfeifer K; Ehmer M; Hüttner C; Blohmer JU; Kiechle M
    Zentralbl Gynakol; 2003 Sep; 125(9):338-45. PubMed ID: 14569515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.
    Melnikow J; Paterniti D; Azari R; Kuenneth C; Birch S; Kuppermann M; Nuovo J; Keyzer J; Henderson S
    Cancer; 2005 May; 103(10):1996-2005. PubMed ID: 15825209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast cancer prevention--awareness and health behavior changes in women in 1998-2002].
    Jokiel M; Bielska-Lasota M; Kraszewska E
    Przegl Epidemiol; 2003; 57(3):521-30. PubMed ID: 14682172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do women know that the risk of breast cancer increases with age?
    Moser K; Patnick J; Beral V
    Br J Gen Pract; 2007 May; 57(538):404-6. PubMed ID: 17504593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer prevention in countries with diverse resources.
    McTiernan A; Porter P; Potter JD
    Cancer; 2008 Oct; 113(8 Suppl):2325-30. PubMed ID: 18837024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
    Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
    J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.